| PICTET - BIOTECH HI EUR | RVI BIOTECNOLOGÍA | 24,64% | 96,06% | 36,63% | 136,95% |
| UBS (LUX) KEY SELECTION SICAV - ASIAN EQUITIES (USD) (GBP) P-DIST | RVI ASIA EX-JAPÓN | 20,41% | 64,06% | 26,93% | 136,95% |
| AXA IM GLOBAL SMALL CAP EQUITY QI B EUR ACC | RVI GLOBAL SMALL/MID CAP | 24,14% | 70,29% | 54,00% | 136,94% |
| JANUS HENDERSON US VENTURE I2 USD | RVI USA SMALL/MID CAP | 9,25% | 43,29% | 5,19% | 136,93% |
| CARMIGNAC PORTFOLIO ASIA DISCOVERY F EUR ACC | RVI EMERGENTES | 34,42% | 96,45% | 61,51% | 136,91% |
| SPDR MSCI EUROPE HEALTH CARE UCITS ETF | RVI SALUD | 22,25% | 32,81% | 34,35% | 136,91% |
| MFS MERIDIAN EUROPEAN RESEARCH FUND I1-USD | RVI EUROPA | 16,62% | 46,65% | 36,33% | 136,90% |
| BARINGS GLOBAL EMERGING MARKETS FUND I EUR CAP | RVI EMERGENTES | 19,90% | 66,60% | 47,62% | 136,89% |
| M&G (LUX) JAPAN SMALLER COMPANIES FUND USD A ACC | RVI JAPÓN SMALL/MID CAP | 24,77% | 47,23% | 58,42% | 136,82% |
| MIRABAUD-GLOBAL DIVIDEND I CAP USD | RVI GLOBAL | 7,56% | 42,44% | 30,02% | 136,80% |
